Actively Recruiting
Study of Biomarkers and Inflammation in Adults After Solid Organ Transplantation to Predict Health Outcomes
Led by IRCCS Azienda Ospedaliero-Universitaria di Bologna · Updated on 2025-01-14
250
Participants Needed
3
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are studying adult patients who have received solid organ transplants, including heart, liver, lung, or kidney transplants. This observational study aims to measure biological markers related to inflammation, cellular aging, and immune system aging in these patients. The goal is to better understand risks for transplant failure and complications and to guide personalized treatments to improve long-term outcomes. The study involves collecting tissue and blood samples to analyze plasma profiles of cytokines, inflammatory microRNAs, circulating free DNA, extracellular vesicles, and leukocyte profiles. Researchers will also assess systemic and tissue aging through epigenetic clocks. These measurements may help identify patients at higher risk for transplant damage, cardiovascular, kidney, metabolic, or cancer complications, and increased mortality. Participants will be followed for up to seven years to monitor adverse events related to their organ transplant. Biological samples and data will be collected and analyzed to track inflammation and aging markers. This will help researchers evaluate the relationship between these markers and transplant outcomes. The study will monitor safety and effectiveness of any therapeutic or preventive measures based on this biological stratification.
CONDITIONS
Brief Title
Biomarkers and Inflammation in Solid Organ Transplantation: Relationship With Short- and Long-Term Outcomes
Research Team
M
Marco Masetti, MD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here